6 rezultatima
The invention is related to novel lipoamino acids, lipodipeptides and lipotripeptides, their production and use as active pharmaceutical substances.
BACKGROUND OF THE INVENTION
The derivatives according to the general formula
in which n=11-20 and R=amino acid, its D- and L-enantiomers, di- and
FIELD OF THE INVENTION
The present invention is directed to novel bradykinin (BK.sub.2) receptor modulators, pharmaceutical compositions containing them and their use in the treatment of bradykinin (BK) modulated disorders. More particularly, the present invention is directed to novel alkylamide
FIELD OF THE INVENTION
The present invention is directed to novel bradykinin (BK.sub.2) receptor modulators, pharmaceutical compositions containing them and their use in the treatment of bradykinin (BK) modulated disorders. More particularly, the present invention is directed to novel alkylamide
FIELD OF THE INVENTION
The present invention relates to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an active compound of .omega.-(methylsulfonyl)alkylamine or .omega.-(methylsulfonyl)alkylamide, or its pharmaceutically acceptable salts. The present invention
FIELD OF THE INVENTION
The present invention relates to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an active compound of .omega.-(methylsulfonyl)alkylamine or .omega.-(methylsulfonyl)alkylamide, or its pharmaceutically acceptable salts. The present invention
FIELD OF THE INVENTION
The present invention relates to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an active compound of .omega.-(methylsulfonyl)alkylamine or .omega.-(methylsulfonyl)alkylamide, or its pharmaceutically acceptable salts. The present invention